{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Gabapentin+400+mg+capsules", "query": { "intervention": "Gabapentin 400 mg capsules" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Gabapentin+400+mg+capsules&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-23T00:16:02.017Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00865631", "title": "A Limited Food Effect Study of Gabapentin 800 mg Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Gabapentin 800 mg tablets, single dose (1 tablet)", "type": "DRUG" }, { "name": "NEURONTIN® 400 mg capsules, single dose (2 capsules)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 18, "start_date": "1999-06", "completion_date": "1999-06", "has_results": false, "last_update_posted_date": "2010-08-17", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00865631" }, { "nct_id": "NCT00420771", "title": "Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Benzodiazepine Dependence", "Opioid Dependence" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 19, "start_date": "2007-01", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2019-04-24", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Long Island City, New York", "locations": [ { "city": "Long Island City", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00420771" }, { "nct_id": "NCT00864305", "title": "A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Gabapentin 400 mg capsules", "type": "DRUG" }, { "name": "NEURONTIN® 400 mg capsules", "type": "DRUG" }, { "name": "Gabapentin 400 mg capsules, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 18, "start_date": "1997-12", "completion_date": "1998-01", "has_results": false, "last_update_posted_date": "2010-08-17", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00864305" }, { "nct_id": "NCT00654953", "title": "Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent Humans", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cocaine Dependence", "Depressive Symptoms" ], "interventions": [ { "name": "sertraline", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 102, "start_date": "2006-01", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2011-04-25", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00654953" }, { "nct_id": "NCT00733239", "title": "Drug Discrimination in Methadone-Maintained Humans Study 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Opioid Dependence" ], "interventions": [ { "name": "2-4 of the drugs listed below", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 15, "start_date": "2008-08", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2012-04-18", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00733239" }, { "nct_id": "NCT00864058", "title": "A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Gabapentin 400 mg capsules", "type": "DRUG" }, { "name": "NEURONTIN® 400 mg capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 30, "start_date": "1998-01", "completion_date": "1998-01", "has_results": false, "last_update_posted_date": "2010-08-17", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00864058" }, { "nct_id": "NCT01141049", "title": "Gabapentin for Abstinence Initiation in Alcohol Dependence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Alcohol Dependence" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2010-08", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2019-04-24", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01141049" }, { "nct_id": "NCT02330094", "title": "Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Aneurysmal Subarachnoid Hemorrhage" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2014-12", "completion_date": "2017-09-01", "has_results": true, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02330094" }, { "nct_id": "NCT02703259", "title": "Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Christiana Care Health Services", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 137, "start_date": "2016-06", "completion_date": "2017-07", "has_results": true, "last_update_posted_date": "2020-05-20", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Newark, Delaware", "locations": [ { "city": "Newark", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT02703259" }, { "nct_id": "NCT00864760", "title": "A Relative Bioavailability Study of Gabapentin 800 mg Tablets Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Gabapentin 800 mg tablets, single dose (1 tablet)", "type": "DRUG" }, { "name": "NEURONTIN® 400 mg capsules, single dose (2 capsules)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 30, "start_date": "1999-06", "completion_date": "1999-06", "has_results": false, "last_update_posted_date": "2010-08-17", "last_synced_at": "2026-09-23T00:16:02.017Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00864760" } ] }